Cancer Vaccines
Concept
Vocabulary Service
Overview
subject area of
-
A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma Academic Article
-
A Long, Naturally Presented Immunodominant Epitope from NY-ESO-1 Tumor Antigen: Implications for Cancer Vaccine Design Academic Article
-
A direct comparison of cytolytic T-lymphocyte responses to Melan-A peptides in vitro: differential immunogenicity of Melan-A27-35 and Melan-A26-35 Academic Article
-
A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvant Academic Article
-
Activation of anti-tumor cytotoxic T lymphocytes by fusion of human dendritic cells and melanoma cells Academic Article
-
An HLA-A2 polyepitope vaccine for melanoma immunotherapy Academic Article
-
Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette-Guerin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma Academic Article
-
Blood Dendritic Cells Generated With Flt3 Ligand and CD40 Ligand Prime CD8+ T Cells Efficiently in Cancer Patients Academic Article
-
CD8+ T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients Academic Article
-
Cancer vaccines: Where are we going? Academic Article
-
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells Academic Article
-
Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination Academic Article
-
Clinical promise of tumour immunology Academic Article
-
Development of a novel, quantitative protein microarray platform for the multiplexed serological analysis of autoantibodies to cancer-testis antigens Academic Article
-
Directions in the immune targeting of cancer: Lessons learned from the cancer‐testis Ag NY‐ESO‐1 Academic Article
-
Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting Academic Article
-
Evaluation of cellular immune responses in cancer vaccine recipients: lessons from NY-ESO-1 Academic Article
-
Evolving role of tumor antigens for future melanoma therapies Academic Article
-
Fine-mapping naturally occurring NY-ESO-1 antibody epitopes in melanoma patients’ sera using short overlapping peptides and full-length recombinant protein Academic Article
-
Functional and Structural Characteristics of NY-ESO-1-related HLA A2-restricted Epitopes and the Design of a Novel Immunogenic Analogue Academic Article
-
HER2-Specific T-Cell Immune Responses in Patients Vaccinated with Truncated HER2 Protein Complexed with Nanogels of Cholesteryl Pullulan Academic Article
-
Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel Academic Article
-
ISCOMATRIX Adjuvant Induces Efficient Cross-Presentation of Tumor Antigen by Dendritic Cells via Rapid Cytosolic Antigen Delivery and Processing via Tripeptidyl Peptidase II Academic Article
-
Immunodominance and Immunodomination: Critical Factors in Developing Effective CD8+ T‐Cell–Based Cancer Vaccines Book
-
Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™ Academic Article
-
Immunotherapy of melanoma: Targeting defined antigens Academic Article
-
Influenza A Infection Enhances Cross-Priming of CD8+T Cells to Cell-Associated Antigens in a TLR7- and Type I IFN-Dependent Fashion Academic Article
-
Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy Academic Article
-
Lentivector immunization induces tumor antigen‐specific B and T cell responsesin vivo Academic Article
-
Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX (TM) vaccine in patients with advanced melanoma Academic Article
-
Mannan-MUC1-Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with Adenocarcinoma Academic Article
-
Melanoma vaccines: developments over the past 10 years Academic Article
-
NY-ESO-1 Protein Formulated in ISCOMATRIX Adjuvant Is a Potent Anticancer Vaccine Inducing Both Humoral and CD8+ T-Cell-Mediated Immunity and Protection against NY-ESO-1+ Tumors Academic Article
-
Optimal conditions required for influenza A infection‐enhanced cross‐priming of CD8
+
T cells specific to cell‐associated antigens Academic Article
-
Perspective: cancer vaccines in the era of immune checkpoint blockade Academic Article
-
Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen delivery Academic Article
-
Rational approaches to human cancer immunotherapy Academic Article
-
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad antibody responses in humans, a RAYS-based analysis Academic Article
-
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans Academic Article
-
Recombinant NY‐ESO‐1 Cancer Antigen: Production and Purification under cGMP Conditions Academic Article
-
Regulatory T-Cell-Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma Academic Article
-
T Cell Determinants Incorporating β-Amino Acid Residues Are Protease Resistant and Remain Immunogenic In Vivo Academic Article
-
T cells recognizing a 11mer influenza peptide complexed to H-2D(b) show promiscuity for peptide length Academic Article
-
Targeted therapy of renal cell carcinoma: Synergistic activity of cG250-TNF and IFNg Academic Article
-
Telomerase in cancer immunotherapy Academic Article
-
The Efficacy of Epidermal Growth Factor Receptor-Specific Antibodies against Glioma Xenografts Is Influenced by Receptor Levels, Activation Status, and Heterodimerization Academic Article
-
The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning. Academic Article
-
The immune suppressive function of transforming growth factor-β (TGF-β) in human diseases Academic Article
-
The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand. Academic Article
-
The therapeutic benefit of bacterial membrane vesicles Academic Article
-
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1 Academic Article
-
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery Academic Article
-
Tumor-Specific T-cell Help Is Associated with Improved Survival in Melanoma Editorial Article
-
Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma. Academic Article